Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Umbilical Cord Mesenchymal Stem Cells Therapy for Patients With Lumbar Discogenic Pain
NCT04104412Phase 1Recruiting
- Sponsor
- Sclnow Biotechnology Co., Ltd.
- Start
- Aug 2019
- Primary completion
- Dec 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1 trial of human umbilical cord mesenchymal stem cells in lumbar discogenic pain (DLP) (2 arms), sponsored by Sclnow Biotechnology Co., Ltd. Primary endpoint: Visual Analogue Scale pain score relief rate at 24 weeks. Started Aug 2019; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
lumbar discogenic pain (DLP)
Beyond the preview
Go deeper on NCT04104412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04104412.